Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
4
×
biotech
boston blog main
boston top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
investing
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
alzheimer's disease
biogen
clinical trials
crispr therapeutics
dicerna pharmaceuticals
What
bio
roundup
alzheimer’s
companies
drug
pharmaceutical
prices
typically
abandoning
ago
annual
assessed
attention
baggage
bails
biotech
brand
bridgebio
capital
car
communities
conference
cuts
deal
develop
development
dicerna
different
drugs
emerges
esmo
europe
fail
firm
free
gene
germany
gets
grab
headlines
Language
unset
Current search:
" alexion pharmaceuticals "
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More